Therapeutic effects of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy

被引：0
|
作者：
李佩瑾 [1 ]
机构：
[1] Dept Cardiol,Anzhen Hosp,Capital Med Univ,Beijing Instit Heart Lung & Blood Vessel Dis
来源：
ChinaMedicalAbstracts(InternalMedicine) | 2022年 / 39卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R542.2 [心肌疾病];
学科分类号：
摘要：
Objective To observe the therapeutic effects of alcohol septal ablation (ASA) in mildly symptomatic patients(NYHA classⅡ) with hypertrophic obstructive cardiomyopathy(HOCM).Methods This retrospective study included 150 mildly symptomatic patients with HOCM hospitalized in Beijing Anzhen Hospital affiliated to Capital Medical University from March 2001 to December2017, consisting of medical therapy group (n=102) and ASA group (n=48). Baseline clinical data were collected, and patients were followed up to a mean of 6.0 (3.5, 8.1) years.
引用
收藏
页码：95 / 96
页数：2
相关论文
共 50 条
  • [41] Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: focus on safety
    Veselka, Josef
    SWISS MEDICAL WEEKLY, 2007, 137 (47-48) : 657 - 659
  • [42] Comparison of Alcohol Septal Ablation with Mavacamten in Obstructive Hypertrophic Cardiomyopathy
    Samhan, Ashraf
    Saleh, Danish
    Kim, Ellis
    Hu, Mo
    Mueller, Kayla
    Garza, Abigail
    Baldridge, Abigail
    Puthumana, Jyothy
    Flaherty, James
    Choudhury, Lubna
    CIRCULATION, 2024, 150
  • [43] Septal alcohol ablation in hypertrophic obstructive cardiomyopathy: A retrospective analysis
    Yavuzgil, Oguz
    Tuluce, Kamil
    Simsek, Evrim
    Gurgun, Cemil
    Kultursay, Hakan
    Payzin, Serdar
    Hasdemir, Can
    Can, Levent Hurkan
    Turkoglu, Cuneyt
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 20 (03): : 427 - 433
  • [44] Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy
    Lawin, Dennis
    Lawrenz, Thorsten
    Marx, Kristin
    Danielsmeier, Nils Benedikt
    Poudel, Madan Raj
    Stellbrink, Christoph
    HEART, 2022, 108 (20) : 1623 - 1628
  • [45] Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: A review of the literature
    Veselka, Josef
    MEDICAL SCIENCE MONITOR, 2007, 13 (04): : RA62 - RA68
  • [46] Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy A Word of Endorsement
    Liebregts, Max
    Vriesendorp, Pieter A.
    ten Berg, Jurrien M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (04) : 481 - 488
  • [47] Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy A Word of Balance
    Sorajja, Paul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (04) : 489 - 494
  • [48] Comparison of Alcohol Septal Ablation With Mavacamten in Obstructive Hypertrophic Cardiomyopathy
    Samhan, Ashraf
    Saleh, Danish
    Kim, Ellis Y.
    Hu, Mo
    Mueller, Kayla
    Garza, Abigail
    Schormann, Elizabeth
    Bindra, Parmeen
    Cheema, Baljash
    Fullenkamp, Dominic E.
    Baldridge, Abigail S.
    Puthumana, Jyothy J.
    Flaherty, James D.
    Choudhury, Lubna
    AMERICAN JOURNAL OF CARDIOLOGY, 2025, 239 : 51 - 56
  • [49] Alcohol septal ablation in hypertrophic obstructive cardiomyopathy - The need for a registry
    Spencer, WH
    Roberts, R
    CIRCULATION, 2000, 102 (06) : 600 - 601
  • [50] Alcohol Septal Ablation: An Option on the Rise in Hypertrophic Obstructive Cardiomyopathy
    Arevalos, Victor
    Rodriguez-Arias, Juan Jose
    Brugaletta, Salvatore
    Micari, Antonio
    Costa, Francesco
    Freixa, Xavier
    Masotti, Monica
    Sabate, Manel
    Regueiro, Ander
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)
12345